Published in Hum Immunol on February 01, 2003
Characterization of HCV-specific CD4+Th17 immunity in recurrent hepatitis C-induced liver allograft fibrosis. Am J Transplant (2011) 0.89
Inflammatory status in human hepatic cirrhosis. World J Gastroenterol (2015) 0.86
Immune response to extracellular matrix collagen in chronic hepatitis C-induced liver fibrosis. Liver Transpl (2011) 0.86
Characterization of virus-specific T-cell immunity in liver allograft recipients with HCV-induced cirrhosis. Am J Transplant (2008) 0.85
The peritoneal macrophage inflammatory profile in cirrhosis depends on the alcoholic or hepatitis C viral etiology and is related to ERK phosphorylation. BMC Immunol (2012) 0.82
T-helper cells and liver fibrosis in hepatitis C virus-monoinfected patients. J Viral Hepat (2009) 0.80
Temporal association between increased virus-specific Th17 response and spontaneous recovery from recurrent hepatitis C in a liver transplant recipient. Transplantation (2011) 0.77
Review of cytokine profiles in patients with hepatitis. World J Gastroenterol (2004) 0.76
The effect of tolerance to noninherited maternal HLA antigens on the survival of renal transplants from sibling donors. N Engl J Med (1998) 3.86
Comprehensive assessment and standardization of solid phase multiplex-bead arrays for the detection of antibodies to HLA. Am J Transplant (2013) 2.45
The economic implications of HLA matching in cadaveric renal transplantation. N Engl J Med (1999) 2.18
Predicting outcome after liver transplantation: utility of the model for end-stage liver disease and a newly derived discrimination function. Transplantation (2004) 2.13
Liver Resection and Transplantation for Patients With Hepatocellular Carcinoma Beyond Milan Criteria. Ann Surg (2016) 2.05
Persistent and fatal central-nervous-system ECHOvirus infections in patients with agammaglobulinemia. N Engl J Med (1977) 1.85
Fluorodeoxyglucose PET imaging in the evaluation of gallbladder carcinoma and cholangiocarcinoma. J Gastrointest Surg (2004) 1.77
Efficacy of neoadjuvant chemoradiation, followed by liver transplantation, for perihilar cholangiocarcinoma at 12 US centers. Gastroenterology (2012) 1.70
CD4+25+ regulatory T cells limit Th1-autoimmunity by inducing IL-10 producing T cells following human lung transplantation. Am J Transplant (2006) 1.63
Human leukemia cell antigens: serologic characterization with xenoantisera. J Natl Cancer Inst (1974) 1.60
Immune response to tissue-restricted self-antigens induces airway inflammation and fibrosis following murine lung transplantation. Am J Transplant (2014) 1.56
Incorporation of a laser range scanner into image-guided liver surgery: surface acquisition, registration, and tracking. Med Phys (2003) 1.52
Concepts and preliminary data toward the realization of image-guided liver surgery. J Gastrointest Surg (2007) 1.50
Anti-HLA class I antibody binding to airway epithelial cells induces production of fibrogenic growth factors and apoptotic cell death: a possible mechanism for bronchiolitis obliterans syndrome. Hum Immunol (2003) 1.50
Robust surface registration using salient anatomical features for image-guided liver surgery: algorithm and validation. Med Phys (2008) 1.49
Compensating for intraoperative soft-tissue deformations using incomplete surface data and finite elements. IEEE Trans Med Imaging (2005) 1.49
CpG island methylation of genes accumulates during the adenoma progression step of the multistep pathogenesis of colorectal cancer. Genes Chromosomes Cancer (2006) 1.44
HLA-A locus mismatches and development of antibodies to HLA after lung transplantation correlate with the development of bronchiolitis obliterans syndrome. Transplantation (1998) 1.41
Surgical treatment of hepatocellular carcinoma: expert consensus statement. HPB (Oxford) (2010) 1.40
A novel reduced-intensity stem cell transplant regimen for nonmalignant disorders. Bone Marrow Transplant (2005) 1.39
Development of ELISA-detected anti-HLA antibodies precedes the development of bronchiolitis obliterans syndrome and correlates with progressive decline in pulmonary function after lung transplantation. Transplantation (1999) 1.28
Immune mechanisms in the pathogenesis of bronchiolitis obliterans syndrome after lung transplantation. Pediatr Transplant (2005) 1.27
Effect of development of antibodies to HLA and cytomegalovirus mismatch on lung transplantation survival and development of bronchiolitis obliterans syndrome. J Thorac Cardiovasc Surg (1998) 1.26
Immunological link between primary graft dysfunction and chronic lung allograft rejection. Ann Thorac Surg (2008) 1.24
Disparate outcomes in patients with colorectal cancer: effect of race on long-term survival. Arch Surg (2002) 1.24
Characterization of human IgG Fc receptors. J Immunol (1985) 1.21
Expression of a new cell surface antigen on activated murine macrophages. J Exp Med (1977) 1.21
Late primary graft dysfunction after lung transplantation and bronchiolitis obliterans syndrome. Am J Transplant (2008) 1.19
Recognition of HLA-A2-restricted mammaglobin-A-derived epitopes by CD8+ cytotoxic T lymphocytes from breast cancer patients. Breast Cancer Res Treat (2004) 1.19
Antibodies to K-α 1 tubulin and collagen V are associated with chronic rejection after lung transplantation. Am J Transplant (2012) 1.19
In vivo biotinylation of the major histocompatibility complex (MHC) class II/peptide complex by coexpression of BirA enzyme for the generation of MHC class II/tetramers. Hum Immunol (2004) 1.17
Prevalence and outcome of bronchiolitis obliterans syndrome after lung transplantation. Washington University Lung Transplant Group. Ann Thorac Surg (1995) 1.15
Prolonged cold-preservation of nerve allografts. Muscle Nerve (2005) 1.14
Broad histopathologic patterns of non-glabrous skin and glabrous skin from patients with a new variant of endemic pemphigus foliaceus-part 1. J Cutan Pathol (2009) 1.14
The role of [18F]fluorodeoxyglucose positron emission tomography imaging in the evaluation of hepatocellular carcinoma. Am Surg (2003) 1.12
Perivascular endothelial implants inhibit intimal hyperplasia in a model of arteriovenous fistulae: a safety and efficacy study in the pig. J Vasc Res (2003) 1.12
Cyclosporine in cardiac transplantation. Surg Clin North Am (1985) 1.11
Pre-liver transplantation locoregional adjuvant therapy for hepatocellular carcinoma as a strategy to improve longterm survival. J Am Coll Surg (2006) 1.11
Airway epithelium is the primary target of allograft rejection in murine obliterative airway disease. Am J Transplant (2004) 1.09
Monoclonal antibody to human IgG Fc receptors. Cross-linking of receptors induces lysosomal enzyme release and superoxide generation by neutrophils. J Immunol (1988) 1.08
Antigens specific for human lymphocytic and myeloid leukemia cells: detection by nonhuman primate antiserums. Science (1972) 1.08
Accelerated coronary arteriosclerosis in cardiac transplant recipients. Transplant Rev (Orlando) (1987) 1.08
Properties of two monoclonal antibodies directed against the Fc and Fab' regions of rat IgE. Int Arch Allergy Appl Immunol (1983) 1.06
Combined hepatocellular and cholangiocarcinoma (biphenotypic) tumors: imaging features and diagnostic accuracy of contrast-enhanced CT and MRI. AJR Am J Roentgenol (2013) 1.06
A model to predict severe HCV-related disease following liver transplantation. Hepatology (2003) 1.06
Hepatic arterial chemoembolization for hepatocellular carcinoma: comparison of survival rates with different embolic agents. J Vasc Interv Radiol (2005) 1.06
Hepatitis C treatment and SVR: the gap between clinical trials and real-world treatment aspirations. Gen Hosp Psychiatry (2012) 1.05
Indirect recognition of donor HLA class I peptides in lung transplant recipients with bronchiolitis obliterans syndrome. Transplantation (1999) 1.04
Induction of obliterative airway disease by anti-HLA class I antibodies. Am J Transplant (2005) 1.03
Tenofovir disoproxil fumarate therapy for chronic hepatitis B in human immunodeficiency virus/hepatitis B virus-coinfected individuals for whom interferon-alpha and lamivudine therapy have failed. J Infect Dis (2002) 1.03
Interplay between immune responses to HLA and non-HLA self-antigens in allograft rejection. Hum Immunol (2013) 1.02
Interleukin-6 and interferon-gamma gene polymorphisms in the development of bronchiolitis obliterans syndrome after lung transplantation. Transplantation (2002) 1.02
Nonalcoholic fatty liver disease. Ann Hepatol (2004) 1.02
Outcomes of liver transplantation in 490 patients with hepatocellular carcinoma: validation of a uniform staging after surgical treatment. J Am Coll Surg (2007) 1.01
Response of established human breast tumors to vaccination with mammaglobin-A cDNA. J Natl Cancer Inst (2004) 1.01
Different kinetics of obliterative airway disease development in heterotopic murine tracheal allografts induced by CD4+ and CD8+ T cells. Transplantation (2002) 1.00
Temporal relationship between the development of anti-HLA antibodies and the development of bronchiolitis obliterans syndrome after lung transplantation. Transplant Proc (1999) 1.00
Endoplasmic reticulum stress is a mediator of posttransplant injury in severely steatotic liver allografts. Liver Transpl (2011) 1.00
Indirect allorecognition of mismatched donor HLA class II peptides in lung transplant recipients with bronchiolitis obliterans syndrome. Am J Transplant (2001) 1.00
Donor-specific transfusions have long-term beneficial effects for human renal allografts. Transplantation (1995) 0.99
Pre-exposure to sub-saturating concentrations of HLA class I antibodies confers resistance to endothelial cells against antibody complement-mediated lysis by regulating Bad through the phosphatidylinositol 3-kinase/Akt pathway. Eur J Immunol (2004) 0.99
Evidence that pediatric liver transplant recipients may undergo late rejection episodes in spite of donor-specific microchimerism. Transplantation (1996) 0.98
Relationships between membrane antigens of human leukemic cells and oncogenic RNA virus structural components. J Exp Med (1976) 0.98
Cloning of a unique human homologue of the Escherichia coli DNAJ heat shock protein. Biochim Biophys Acta (1993) 0.98
HIF-1α signaling by airway epithelial cell K-α1-tubulin: role in fibrosis and chronic rejection of human lung allografts. Cell Immunol (2011) 0.97
Comparison of MELD and Child-Pugh scores to predict survival after chemoembolization for hepatocellular carcinoma. J Vasc Interv Radiol (2004) 0.97
Sirolimus conversion in liver transplant recipients with renal dysfunction: a prospective, randomized, single-center trial. Transplantation (2007) 0.97
Inhibition of obliterative airway disease development in murine tracheal allografts by matrix metalloproteinase-9 deficiency. Am J Transplant (2005) 0.97
Outcomes in Adults With Acute Liver Failure Between 1998 and 2013: An Observational Cohort Study. Ann Intern Med (2016) 0.97
Cytolytic effector mechanisms of human CD4+ cytotoxic T lymphocytes. Hum Immunol (1996) 0.96
Alterations in human regulatory T lymphocytes subpopulations after renal allografting. J Immunol (1981) 0.96
Improved islet yields from pancreas preserved in perflurocarbon is via inhibition of apoptosis mediated by mitochondrial pathway. Am J Transplant (2006) 0.96
Evidence for cross-regulation of Fc gamma RIIIB (CD16) receptor-mediated signaling by Fc gamma RII (CD32) expressed on polymorphonuclear neutrophils. J Immunol (1992) 0.96
Activation of human airway epithelial cells by non-HLA antibodies developed after lung transplantation: a potential etiological factor for bronchiolitis obliterans syndrome. Transplantation (2001) 0.95
Genetic studies of an acardiac monster: evidence of polar body twinning in man. Science (1981) 0.95
Systemic nf-kappaB activation in a transgenic mouse model of acute pancreatitis. J Surg Res (2003) 0.95
Safety and immunogenicity observations pooled from eight clinical trials of recombinant human thrombin. J Am Coll Surg (2009) 0.95
Endotoxin potentiates lung injury in cerulein-induced pancreatitis. Am J Surg (2003) 0.95
Pertussis toxin inhibits human neutrophil responses mediated by the 42-kilodalton IgG Fc receptor. J Immunol (1988) 0.95
Hepatocellular carcinoma: a review of the surgical approaches to management. Mo Med (2011) 0.94
Hepatitis C virus-induced changes in microRNA 107 (miRNA-107) and miRNA-449a modulate CCL2 by targeting the interleukin-6 receptor complex in hepatitis. J Virol (2014) 0.94
A shift in the collagen V antigenic epitope leads to T helper phenotype switch and immune response to self-antigen leading to chronic lung allograft rejection. Clin Exp Immunol (2012) 0.94
The association of HLA class II with pars planitis. Am J Ophthalmol (2001) 0.94
SALL4 immunoreactivity predicts prognosis in Western hepatocellular carcinoma patients but is a rare event: a study of 236 cases. Am J Surg Pathol (2014) 0.94
Relationship of expression of A cell-surface antigen on activated murine macrophages to tumor cell cytotoxicity. J Immunol (1978) 0.94
Enumeration of transferrin-receptor-expressing lymphocytes as a potential marker for rejection in human cardiac transplant recipients. Transplantation (1986) 0.94
Previously unreported high-grade complications of adrenalectomy. Surg Endosc (2008) 0.93